[Large intestine dysbacteriosis and therapy efficacy in patients with respiratory tract tuberculosis in sanatoria].
Long-term chemotherapy of tuberculosis leads to dysbacteriosis of the large intestine, that significantly decreases tolerance of tuberculosis drugs, provokes persistence of tuberculosis intoxication and retards involution of tuberculosis process in the lungs. Recovery of the bifidoflora and lactoflora due to the use of an original sour-milk drink developed by the authors was stated in 65 and 55% of the patients respectively. Moreover, it promoted higher tolerance of the chemotherapeutics since its composition includes amino acids, vitamins B, C, D and E, enzymes and microelements. It should be indicated that the drink was used simultaneously with the chemotherapy and did not require its discontinuation. Therefore, it is recommended that the scheme of the treatment of patients with pulmonary tuberculosis in sanatoria should include corrigating agents and in particular probiotics containing live bifido- and lactobacteria having no contraindications and side effects, and providing elimination of intestinal dysbacteriosis.
N N
NN
Dugina
T V
TV
Chebotareva
S D
SD
Mitrokhin
D000284:Administration, Oral; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D043302:Cultured Milk Products; D004361:Drug Tolerance; D005260:Female; D006294:Health Resorts; D006801:Humans; D007410:Intestinal Diseases / Q000139:chemically induced / Q000382:microbiology / Q000628:therapy*; D007420:Intestine, Large / Q000382:microbiology*; D007778:Lactobacillus / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
D000995:Antitubercular Agents